Adaptive Biotechnologies Corporation
ADPT
$12.63
$0.3352.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.60% | 8.61% | 5.10% | -1.34% | -10.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.60% | 8.61% | 5.10% | -1.34% | -10.99% |
| Cost of Revenue | -3.50% | -7.87% | -38.64% | -74.50% | -71.32% |
| Gross Profit | 34.50% | 17.87% | 61.65% | 828.79% | 1,192.28% |
| SG&A Expenses | -2.50% | -8.87% | -8.66% | -8.78% | -8.10% |
| Depreciation & Amortization | -0.35% | -0.23% | 0.24% | 0.29% | 0.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.88% | -11.41% | -10.11% | -8.11% | -6.59% |
| Operating Income | 34.70% | 29.50% | 22.95% | 14.35% | 2.19% |
| Income Before Tax | 43.23% | 34.05% | 29.16% | 0.34% | -11.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.23% | 34.05% | 29.16% | 0.34% | -11.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -92.31% | -30.38% | 90.74% | 50.72% | 28.40% |
| Net Income | 43.21% | 34.05% | 29.19% | 0.36% | -11.81% |
| EBIT | 34.70% | 29.50% | 22.95% | 14.35% | 2.19% |
| EBITDA | 37.33% | 31.40% | 24.13% | 15.07% | 2.25% |
| EPS Basic | 44.49% | 35.36% | 30.45% | 1.85% | -10.21% |
| Normalized Basic EPS | 35.14% | 31.19% | 24.87% | 16.66% | 5.10% |
| EPS Diluted | 44.49% | 35.36% | 30.45% | 1.85% | -10.21% |
| Normalized Diluted EPS | 35.14% | 31.19% | 24.87% | 16.66% | 5.10% |
| Average Basic Shares Outstanding | 2.34% | 2.07% | 1.88% | 1.73% | 1.55% |
| Average Diluted Shares Outstanding | 2.34% | 2.07% | 1.88% | 1.73% | 1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |